64 related articles for article (PubMed ID: 28454573)
1. Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Oh YT; Kang SH
BMC Cancer; 2017 Apr; 17(1):297. PubMed ID: 28454573
[TBL] [Abstract][Full Text] [Related]
2. Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
Kim SI; Kim JY; Wee CW; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Park NH; Song YS; Kim TH
BMC Cancer; 2021 Nov; 21(1):1260. PubMed ID: 34809599
[TBL] [Abstract][Full Text] [Related]
3. Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study.
Wang Y; Lyu Y; Che X; Li J; Feng W
J Gynecol Oncol; 2024 May; 35(3):e36. PubMed ID: 38216135
[TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Value of Adjuvant Chemotherapy after Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
Wang YN; Zhong ML; Liang MR; Yang JT; Zeng SY
Gynecol Obstet Invest; 2023; 88(5):286-293. PubMed ID: 37497957
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer: The POHIM-CCRT Nonrandomized Controlled Trial.
Cho WK; Park W; Kim SW; Lee KK; Ahn KJ; Choi JH
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38662364
[TBL] [Abstract][Full Text] [Related]
6. The Role of Galectins in Cervical Cancer Biology and Progression.
Wang L; Zhao Y; Wang Y; Wu X
Biomed Res Int; 2018; 2018():2175927. PubMed ID: 29854732
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer: A global health crisis.
Small W; Bacon MA; Bajaj A; Chuang LT; Fisher BJ; Harkenrider MM; Jhingran A; Kitchener HC; Mileshkin LR; Viswanathan AN; Gaffney DK
Cancer; 2017 Jul; 123(13):2404-2412. PubMed ID: 28464289
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
Bourgeois H; Grudé F; Solal-Céligny P; Dupuis O; Voog E; Ganem G; Denis F; Zinger M; Juhel-Voog L; Lafond C; Maillart P; Capitain O; Delva R; Soulié P; Abadie-Lacourtoisie S; Guérin-Meyer V; Morin-Meschin ME; Commer JM; Gangler A; d'Aillières B; Zannetti A; Bourbouloux E; Berton-Rigault D; Lebouvier-Sadot S; Kaassis M; Baudon J; Lam YH; Bizieux A; Marcq M; Edeline J; Le Du F; Lefeuvre C; Deguiral P; Delecroix V; Blot E; Egreteau J; Goudier MJ; Lamy R; Ferec M; Artignan X; Corbinais S; Morel H; Hardy-Bessard AC; Alleaume C; Naudeix E; Cojocarasu O; Metges JP; Riché C; Gamelin E; Déniel-Lagadec D; Marhuenda F; Ingrand P; Douillard JY
Ann Oncol; 2017 Jul; 28(7):1612-1617. PubMed ID: 28472235
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy achieved the equivalent survival compared with concurrent chemoradiotherapy in cervical cancer patients with intermediate-risk.
Yu H; Zhang L; Li D; Liu N; Yin Y; Zhang L; Yuan L; Liu M; Sheng X
Jpn J Clin Oncol; 2019 Aug; 49(8):714-718. PubMed ID: 31329905
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract][Full Text] [Related]
11. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
[TBL] [Abstract][Full Text] [Related]
12. The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy.
Zhang Q; Liu Z; Wang Y; Zhang J; Li W; Wang T; Wang J; Shi F; Su J
World J Surg Oncol; 2022 Nov; 20(1):372. PubMed ID: 36443879
[TBL] [Abstract][Full Text] [Related]
13. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
Qin F; Pang H; Yu T; Luo Y; Dong Y
Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
[TBL] [Abstract][Full Text] [Related]
14. Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.
Machida H; Matsuo K; Kobayashi Y; Momomura M; Takahashi F; Tabata T; Kondo E; Yamagami W; Ebina Y; Kaneuchi M; Nagase S; Mikami M
J Gynecol Oncol; 2022 May; 33(3):e26. PubMed ID: 35320882
[TBL] [Abstract][Full Text] [Related]
15. The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement.
Bai Y; Rong L; Hu B; Ma X; Wang J; Chen H
Front Oncol; 2021; 11():764065. PubMed ID: 34804967
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy.
Zhang G; Miao L; Wu H; Zhang Y; Fu C
Technol Cancer Res Treat; 2021; 20():15330338211044626. PubMed ID: 34605696
[No Abstract] [Full Text] [Related]
17. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
18. The Selection of Time Interval Between Surgery and Adjuvant Therapy in Early Stage Cervical Cancer.
You KY; Zhou XH; Jiang YH; Bi ZF; Liu YM; Qiu XS
Int J Gynecol Cancer; 2018 Sep; 28(7):1325-1332. PubMed ID: 30074519
[TBL] [Abstract][Full Text] [Related]
19. Successful management of persistent lower extremity lymphedema with suction-assisted lipectomy.
Micha JP; Nguyen DH; Goldstein BH
Gynecol Oncol Rep; 2018 Feb; 23():13-15. PubMed ID: 29322088
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
